Celcuity (CELC) Competitors

$132.18 -5.50 (-3.99%)

Closing price 04:00 PM Eastern

Extended Trading

$129.40 -2.79 (-2.11%)

As of 07:28 PM Eastern

CELC vs. GH, FMS, BTSG, PACS, and HIMS

Should you buy Celcuity stock or one of its competitors? MarketBeat compares Celcuity with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Celcuity include Guardant Health (GH), Fresenius Medical Care AG & Co. KGaA (FMS), BrightSpring Health Services (BTSG), PACS Group (PACS), and Hims & Hers Health (HIMS). These companies are all part of the "healthcare" industry.

How does Celcuity compare to Guardant Health?

Guardant Health (NASDAQ:GH) and Celcuity (NASDAQ:CELC) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, valuation, institutional ownership, earnings, media sentiment, dividends, profitability and analyst recommendations.

Guardant Health has a beta of 1.48, meaning that its stock price is 48% more volatile than the broader market. Comparatively, Celcuity has a beta of 0.09, meaning that its stock price is 91% less volatile than the broader market.

92.6% of Guardant Health shares are held by institutional investors. Comparatively, 63.3% of Celcuity shares are held by institutional investors. 5.6% of Guardant Health shares are held by company insiders. Comparatively, 13.3% of Celcuity shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Guardant Health presently has a consensus price target of $129.42, indicating a potential upside of 35.29%. Celcuity has a consensus price target of $149.30, indicating a potential upside of 12.95%. Given Guardant Health's stronger consensus rating and higher probable upside, research analysts clearly believe Guardant Health is more favorable than Celcuity.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Guardant Health	1 Sell rating(s)	1 Hold rating(s)	19 Buy rating(s)	0 Strong Buy rating(s)	2.86
Celcuity	1 Sell rating(s)	0 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.83

In the previous week, Celcuity had 1 more articles in the media than Guardant Health. MarketBeat recorded 16 mentions for Celcuity and 15 mentions for Guardant Health. Guardant Health's average media sentiment score of 0.65 beat Celcuity's score of 0.43 indicating that Guardant Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Guardant Health	6 Very Positive mention(s)	2 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Celcuity	4 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	2 Very Negative mention(s)	Neutral

Celcuity has lower revenue, but higher earnings than Guardant Health. Celcuity is trading at a lower price-to-earnings ratio than Guardant Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Guardant Health	$982.02M	12.92	-$416.28M	-$3.39	N/A
Celcuity	N/A	N/A	-$177.04M	-$3.90	N/A

Celcuity has a net margin of 0.00% compared to Guardant Health's net margin of -40.10%. Guardant Health's return on equity of 0.00% beat Celcuity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Guardant Health	-40.10%	N/A	-26.42%
Celcuity	N/A	-244.61%	-50.22%

Summary

Guardant Health beats Celcuity on 11 of the 15 factors compared between the two stocks.

How does Celcuity compare to Fresenius Medical Care AG & Co. KGaA?

Celcuity (NASDAQ:CELC) and Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, risk, media sentiment, profitability, valuation, dividends and earnings.

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.88% compared to Celcuity's net margin of 0.00%. Fresenius Medical Care AG & Co. KGaA's return on equity of 8.90% beat Celcuity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Celcuity	N/A	-244.61%	-50.22%
Fresenius Medical Care AG & Co. KGaA	4.88%	8.90%	4.05%

63.3% of Celcuity shares are owned by institutional investors. Comparatively, 8.4% of Fresenius Medical Care AG & Co. KGaA shares are owned by institutional investors. 13.3% of Celcuity shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Celcuity. Celcuity is trading at a lower price-to-earnings ratio than Fresenius Medical Care AG & Co. KGaA, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Celcuity	N/A	N/A	-$177.04M	-$3.90	N/A
Fresenius Medical Care AG & Co. KGaA	$22.20B	0.56	$1.11B	$1.90	11.70

Celcuity presently has a consensus target price of $149.30, indicating a potential upside of 12.95%. Fresenius Medical Care AG & Co. KGaA has a consensus target price of $28.00, indicating a potential upside of 25.93%. Given Fresenius Medical Care AG & Co. KGaA's higher probable upside, analysts plainly believe Fresenius Medical Care AG & Co. KGaA is more favorable than Celcuity.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Celcuity	1 Sell rating(s)	0 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.83
Fresenius Medical Care AG & Co. KGaA	4 Sell rating(s)	5 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.56

In the previous week, Celcuity had 15 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 16 mentions for Celcuity and 1 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 1.90 beat Celcuity's score of 0.43 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Celcuity	4 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	2 Very Negative mention(s)	Neutral
Fresenius Medical Care AG & Co. KGaA	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Celcuity has a beta of 0.09, suggesting that its stock price is 91% less volatile than the broader market. Comparatively, Fresenius Medical Care AG & Co. KGaA has a beta of 0.81, suggesting that its stock price is 19% less volatile than the broader market.

Summary

Fresenius Medical Care AG & Co. KGaA beats Celcuity on 10 of the 15 factors compared between the two stocks.

How does Celcuity compare to BrightSpring Health Services?

BrightSpring Health Services (NASDAQ:BTSG) and Celcuity (NASDAQ:CELC) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, valuation, analyst recommendations, institutional ownership, dividends, profitability, earnings and risk.

BrightSpring Health Services has a net margin of 2.27% compared to Celcuity's net margin of 0.00%. BrightSpring Health Services' return on equity of 14.63% beat Celcuity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BrightSpring Health Services	2.27%	14.63%	4.41%
Celcuity	N/A	-244.61%	-50.22%

BrightSpring Health Services has higher revenue and earnings than Celcuity. Celcuity is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BrightSpring Health Services	$13.65B	0.80	$190.67M	$1.41	39.84
Celcuity	N/A	N/A	-$177.04M	-$3.90	N/A

63.3% of Celcuity shares are held by institutional investors. 2.8% of BrightSpring Health Services shares are held by company insiders. Comparatively, 13.3% of Celcuity shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

BrightSpring Health Services has a beta of 1.71, suggesting that its stock price is 71% more volatile than the broader market. Comparatively, Celcuity has a beta of 0.09, suggesting that its stock price is 91% less volatile than the broader market.

BrightSpring Health Services presently has a consensus target price of $56.29, indicating a potential upside of 0.19%. Celcuity has a consensus target price of $149.30, indicating a potential upside of 12.95%. Given Celcuity's higher possible upside, analysts clearly believe Celcuity is more favorable than BrightSpring Health Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BrightSpring Health Services	0 Sell rating(s)	0 Hold rating(s)	15 Buy rating(s)	2 Strong Buy rating(s)	3.12
Celcuity	1 Sell rating(s)	0 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.83

In the previous week, Celcuity had 11 more articles in the media than BrightSpring Health Services. MarketBeat recorded 16 mentions for Celcuity and 5 mentions for BrightSpring Health Services. BrightSpring Health Services' average media sentiment score of 0.64 beat Celcuity's score of 0.43 indicating that BrightSpring Health Services is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
BrightSpring Health Services	0 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Celcuity	4 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	2 Very Negative mention(s)	Neutral

Summary

BrightSpring Health Services beats Celcuity on 12 of the 16 factors compared between the two stocks.

How does Celcuity compare to PACS Group?

Celcuity (NASDAQ:CELC) and PACS Group (NYSE:PACS) are both mid-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, earnings, media sentiment, profitability, dividends, risk and institutional ownership.

In the previous week, Celcuity had 7 more articles in the media than PACS Group. MarketBeat recorded 16 mentions for Celcuity and 9 mentions for PACS Group. PACS Group's average media sentiment score of 0.81 beat Celcuity's score of 0.43 indicating that PACS Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Celcuity	4 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	2 Very Negative mention(s)	Neutral
PACS Group	3 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

63.3% of Celcuity shares are held by institutional investors. 13.3% of Celcuity shares are held by insiders. Comparatively, 70.1% of PACS Group shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Celcuity has a beta of 0.09, suggesting that its share price is 91% less volatile than the broader market. Comparatively, PACS Group has a beta of -0.03, suggesting that its share price is 103% less volatile than the broader market.

Celcuity currently has a consensus target price of $149.30, suggesting a potential upside of 12.95%. PACS Group has a consensus target price of $48.00, suggesting a potential upside of 30.41%. Given PACS Group's higher probable upside, analysts clearly believe PACS Group is more favorable than Celcuity.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Celcuity	1 Sell rating(s)	0 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.83
PACS Group	0 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.71

PACS Group has a net margin of 4.49% compared to Celcuity's net margin of 0.00%. PACS Group's return on equity of 26.47% beat Celcuity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Celcuity	N/A	-244.61%	-50.22%
PACS Group	4.49%	26.47%	4.36%

PACS Group has higher revenue and earnings than Celcuity. Celcuity is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Celcuity	N/A	N/A	-$177.04M	-$3.90	N/A
PACS Group	$5.29B	1.10	$191.54M	$1.56	23.59

Summary

PACS Group beats Celcuity on 10 of the 15 factors compared between the two stocks.

How does Celcuity compare to Hims & Hers Health?

Celcuity (NASDAQ:CELC) and Hims & Hers Health (NYSE:HIMS) are both mid-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, institutional ownership, media sentiment, earnings, risk, analyst recommendations, dividends and valuation.

Celcuity currently has a consensus target price of $149.30, indicating a potential upside of 12.95%. Hims & Hers Health has a consensus target price of $29.50, indicating a potential upside of 32.57%. Given Hims & Hers Health's higher possible upside, analysts plainly believe Hims & Hers Health is more favorable than Celcuity.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Celcuity	1 Sell rating(s)	0 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.83
Hims & Hers Health	2 Sell rating(s)	11 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.12

Celcuity has a net margin of 0.00% compared to Hims & Hers Health's net margin of -0.56%. Hims & Hers Health's return on equity of 6.10% beat Celcuity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Celcuity	N/A	-244.61%	-50.22%
Hims & Hers Health	-0.56%	6.10%	1.52%

Hims & Hers Health has higher revenue and earnings than Celcuity. Hims & Hers Health is trading at a lower price-to-earnings ratio than Celcuity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Celcuity	N/A	N/A	-$177.04M	-$3.90	N/A
Hims & Hers Health	$2.37B	2.14	$128.37M	-$0.09	N/A

Celcuity has a beta of 0.09, suggesting that its stock price is 91% less volatile than the broader market. Comparatively, Hims & Hers Health has a beta of 2.43, suggesting that its stock price is 143% more volatile than the broader market.

In the previous week, Hims & Hers Health had 53 more articles in the media than Celcuity. MarketBeat recorded 69 mentions for Hims & Hers Health and 16 mentions for Celcuity. Celcuity's average media sentiment score of 0.43 beat Hims & Hers Health's score of -0.04 indicating that Celcuity is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Celcuity	4 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	2 Very Negative mention(s)	Neutral
Hims & Hers Health	15 Very Positive mention(s)	6 Positive mention(s)	15 Neutral mention(s)	21 Negative mention(s)	7 Very Negative mention(s)	Neutral

63.3% of Celcuity shares are held by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are held by institutional investors. 13.3% of Celcuity shares are held by company insiders. Comparatively, 11.8% of Hims & Hers Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

Hims & Hers Health beats Celcuity on 9 of the 15 factors compared between the two stocks.

Get Celcuity News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CELC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CELC vs. The Competition

Export

Metric	Celcuity	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$6.45B	$3.26B	$6.23B	$12.22B
Dividend Yield	N/A	2.34%	2.80%	5.30%
P/E Ratio	-33.89	18.45	20.66	25.25
Price / Sales	N/A	278.55	546.48	70.60
Price / Cash	N/A	55.27	27.48	37.27
Price / Book	60.91	6.57	9.67	6.63
Net Income	-$177.04M	$24.35M	$3.56B	$335.32M
7 Day Performance	5.21%	-3.17%	-1.91%	-1.83%
1 Month Performance	7.94%	-3.55%	-2.65%	-1.16%
1 Year Performance	1,145.81%	56.89%	31.17%	28.31%

Celcuity Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CELC Celcuity	2.2315 of 5 stars	$132.18 -4.0%	$149.30 +13.0%	+1,197.6%	$6.71B	N/A	N/A	40	Earnings Report Analyst Forecast
GH Guardant Health	3.1974 of 5 stars	$98.69 +2.0%	$129.42 +31.1%	+133.4%	$13.18B	$982.02M	N/A	2,506
FMS Fresenius Medical Care AG & Co. KGaA	4.8592 of 5 stars	$21.94 +0.8%	$28.00 +27.6%	-24.8%	$12.24B	$22.20B	11.53	1,488
BTSG BrightSpring Health Services	2.9475 of 5 stars	$55.12 +0.1%	$56.29 +2.1%	+137.0%	$10.73B	$12.91B	39.23	23,500
PACS PACS Group	4.0967 of 5 stars	$39.59 +24.1%	$44.40 +12.2%	+249.1%	$6.24B	$5.29B	32.27	47,455	Earnings Report Analyst Forecast Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:CELC) was last updated on 5/18/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Celcuity (CELC) Competitors

CELC vs. GH, FMS, BTSG, PACS, and HIMS

How does Celcuity compare to Guardant Health?

Summary

How does Celcuity compare to Fresenius Medical Care AG & Co. KGaA?

Summary

How does Celcuity compare to BrightSpring Health Services?

Summary

How does Celcuity compare to PACS Group?

Summary

How does Celcuity compare to Hims & Hers Health?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CELC vs. The Competition

Celcuity Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Celcuity (CELC) Competitors

CELC vs. GH, FMS, BTSG, PACS, and HIMS

How does Celcuity compare to Guardant Health?

Which has more volatility and risk, GH or CELC?

Do institutionals and insiders believe in GH or CELC?

Do analysts prefer GH or CELC?

Does the media refer more to GH or CELC?

Which has higher earnings and valuation, GH or CELC?

Is GH or CELC more profitable?

Summary

How does Celcuity compare to Fresenius Medical Care AG & Co. KGaA?

Is CELC or FMS more profitable?

Do institutionals & insiders have more ownership in CELC or FMS?

Which has stronger valuation & earnings, CELC or FMS?

Do analysts recommend CELC or FMS?

Does the media prefer CELC or FMS?

Which has more risk and volatility, CELC or FMS?

Summary

How does Celcuity compare to BrightSpring Health Services?

Is BTSG or CELC more profitable?

Which has preferable earnings and valuation, BTSG or CELC?

Do institutionals & insiders believe in BTSG or CELC?

Which has more risk and volatility, BTSG or CELC?

Do analysts recommend BTSG or CELC?

Does the media favor BTSG or CELC?

Summary

How does Celcuity compare to PACS Group?

Does the media refer more to CELC or PACS?

Do insiders & institutionals hold more shares of CELC or PACS?

Which has more risk & volatility, CELC or PACS?

Do analysts rate CELC or PACS?

Is CELC or PACS more profitable?

Which has preferable valuation and earnings, CELC or PACS?

Summary

How does Celcuity compare to Hims & Hers Health?

Do analysts rate CELC or HIMS?

Is CELC or HIMS more profitable?

Which has higher earnings & valuation, CELC or HIMS?

Which has more risk & volatility, CELC or HIMS?

Does the media prefer CELC or HIMS?

Do insiders & institutionals believe in CELC or HIMS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CELC vs. The Competition

Celcuity Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools